Formula & Concentration
Varicella Zoster Immune Globulin (Human)
VARIZIG is a Varicella Zoster Immune Globulin (Human) indicated for postexposure
prophylaxis in high risk individuals (1). High risk groups include:
- immunocompromised children and adults,
- newborns of mothers with varicella shortly before or after delivery,
- premature infants,
- infants less than one year of age,
- adults without evidence of immunity,
- pregnant women.
VARIZIG administration is intended to reduce the severity of varicella.
Shelf Life & Storage
Store VARIZIG at 2 to 8°C (36 to 46°F). Do not freeze. Do not use after expiration date.